Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

European Journal of Cancer

Volumn 49, Issue 13, 2013, Pages 2892-2899

  Laurent, Viviana E ^a   Sampor, Claudia ^a   Solernou, Verónica ^a   Rossi, Jorge ^a   Gabri, Mariano ^b   Eandi Eberle, Silvia ^a   De Davila, Maria T G ^a   Alonso, Daniel F ^b   Chantada, Guillermo L ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

GD2; Metastasis; Retinoblastoma

Indexed keywords

GANGLIOSIDE GD2; MESSENGER RNA;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; GLAUCOMA; HIGH RISK PATIENT; HUMAN; LIQUID; MEDICAL HISTORY; METASTASIS; MINIMALLY DISSEMINATED DISEASE; NUCLEOTIDE SEQUENCE; OPTIC NERVE; PRIORITY JOURNAL; PROBABILITY; RELAPSE; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GD2; METASTASIS; RETINOBLASTOMA;

AGE FACTORS; CHI-SQUARE DISTRIBUTION; CHOROID; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OPTIC NERVE; PREDICTIVE VALUE OF TESTS; RETINAL NEOPLASMS; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84881098134     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.04.021     Document Type: Article

References (32)

1. C.A. Leal-Leal, R. Rivera-Luna, M. Flores-Rojo, J.C. Juarez-Echenique, J.C. Ordaz, and J. Amador-Zarco Survival in extra-orbital metastatic retinoblastoma: treatment results Clin Transl Oncol 8 1 2006 39 44
2. J.M. MacKenzie Malignant meningitis: a rational approach to cerebrospinal fluid cytology J Clin Pathol 49 6 1996 497 499
3. M.L. Greenberg, and L. Goldberg The value of cerebrospinal fluid cytology in the early diagnosis of metastatic retinoblastoma Acta Cytol 21 6 1977 735 738
4. C.B. Pratt, D. Meyer, P. Chenaille, and D.B. Crom The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma J Clin Oncol 7 1 1989 140 143
5. D. Azar, C. Donaldson, and L. Dalla-Pozza Questioning the need for routine bone marrow aspiration and lumbar puncture in patients with retinoblastoma Clin Exp Ophthalmol 31 1 2003 57 60
6. V. Radhakrishnan, S. Kashyap, and N. Pushker Outcome, Pathologic Findings, and Compliance in Orbital Retinoblastoma (International Retinoblastoma Staging System Stage III) Treated with Neoadjuvant Chemotherapy: A Prospective Study Ophthalmology 119 7 2012 1470 1477
7. M.L. Gimblett, P.C. Wellings, M. Lewis, V. Balakrishnan, and R.K. Gupta Retinoblastoma with micrometastasis to CSF Pathology 27 1 1995 27 29
8. C.J. MacKay, D.H. Abramson, and R.M. Ellsworth Metastatic patterns of retinoblastoma Arch Ophthalmol 102 3 1984 391 396
9. K. Kramer, B. Kushner, G. Heller, and N.K. Cheung Neuroblastoma metastatic to the central nervous system. The Memorial Sloan-kettering Cancer Center Experience and a literature review Cancer 91 8 2001 1510 1519
10. T. Kimoto, M. Inoue, and S. Tokimasa Detection of MYCN DNA in the cerebrospinal fluid for diagnosing isolated central nervous system relapse in neuroblastoma Pediatr Blood Cancer 56 5 2011 865 867
11. M.C. Chamberlain, M. Glantz, M.D. Groves, and W.H. Wilson Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment Semin Oncol 36 4, Suppl. 2 2009 S35 S45
12. S.R. Pine, C. Yin, and Y.H. Matloub Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction J Mol Diagn 7 1 2005 127 132
13. K. Beiske, S.A. Burchill, and I.Y. Cheung Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force Br J Cancer 100 10 2009 1627 1637
14. J. Stutterheim, A. Gerritsen, and L. Zappeij-Kannegieter Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers Clin Chem 55 7 2009 1316 1326
15. H. Dimaras, D. Rushlow, and W. Halliday Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma Transl Res 156 2 2010 91 97
16. N. Yamashita, R. Nishiuchi, and M. Oda Molecular detection of metastatic retinoblastoma cells by reverse transcription polymerase reaction for interphotoreceptor retinoid-binding protein mRNA Cancer 91 8 2001 1568 1573
17. V.E. Laurent, L.L. Otero, and V. Vazquez Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma Mol Med Rep 3 2 2010 253 259
18. N.K. Cheung, D.D. Von Hoff, S.E. Strandjord, and P.F. Coccia Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies J Clin Oncol 4 3 1986 363 369
19. H. Shen, Y. Tang, X. Xu, and H. Tang Detection of the GD2+/CD56+/CD45- Immunophenotype by Flow Cytometry in Cerebrospinal Fluids from a Patient with Retinoblastoma Pediatr Hematol Oncol 30 1 2012 30 32
20. G. Chantada, F. Doz, and C.B. Antoneli A proposal for an international retinoblastoma staging system Pediatr Blood Cancer 47 6 2006 801 805
21. G.L. Chantada, A.C. Fandino, and M.R. Guitter Results of a prospective study for the treatment of unilateral retinoblastoma Pediatr Blood Cancer 55 1 2010 60 66
22. J. Palma, D.F. Sasso, and G. Dufort Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America Bone Marrow Transplant 47 4 2012 522 527
23. E. Bellaton, A.I. Bertozzi, and C. Behar Neoadjuvant chemotherapy for extensive unilateral retinoblastoma Br J Ophthalmol 87 3 2003 327 329
24. G.L. Chantada, A. Gonzalez, and A. Fandino Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma J Pediatr Hematol Oncol 31 5 2009 325 329
25. C.L. Shields, J.A. Shields, K. Baez, J.R. Cater, and P. De Potter Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors Cancer 73 3 1994 692 698
26. H.E. Killer, N.R. Miller, and J. Flammer Cerebrospinal fluid exchange in the optic nerve in normal-tension glaucoma Br J Ophthalmol 96 4 2012 544 548
27. M.J. Glantz, B.F. Cole, and L.K. Glantz Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results Cancer 82 4 1998 733 739
28. P. Hersey, O. Jamal, C. Henderson, I. Zardawi, and G. D'Alessandro Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma Int J Cancer 41 3 1988 336 343
29. R. Schumacher-Kuckelkorn, B. Hero, K. Ernestus, and F. Berthold Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases Pediatr Blood Cancer 45 2 2005 195 201
30. G.L. Chantada, J. Rossi, and F. Casco An aggressive bone marrow evaluation including immunocytology with GD2 for advanced retinoblastoma J Pediatr Hematol Oncol 28 6 2006 369 373
31. S. Urbanits, A. Griesmacher, and G. Hopfinger FACS analysis - a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid Clin Chim Acta 317 1-2 2002 101 107
32. M. Bommer, A. Nagy, C. Schopflin, S. Pauls, M. Ringhoffer, and M. Schmid Cerebrospinal fluid pleocytosis: pitfalls and benefits of combined analysis using cytomorphology and flow cytometry Cancer Cytopathol 119 1 2011 20 26